+499.5%
MRNA vs CHRW
+16.7%
+482.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CHRW | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.6% | -2.9% | -2.4% |
| 7D | +5.5% | -1.8% | +7.3% | +5.9% |
| 30D | +158.7% | -3.9% | +162.6% | +161.2% |
| 3M | +182.1% | -19.7% | +201.9% | +194.7% |
| 6M | +151.8% | -21.7% | +173.5% | +165.0% |
| YTD | +393.6% | -7.5% | +401.1% | +354.4% |
| 1Y | +499.5% | +17.3% | +482.2% | +389.2% |
| All | +499.5% | +16.7% | +482.7% | +389.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CHRW.
Daily Out/Under-Performance
Portfolio return minus CHRW return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHRW return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CHRW wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling